Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid

Steroids. 1994 Jul;59(7):436-42. doi: 10.1016/0039-128x(94)90013-2.

Abstract

HeLa S3 cells that contain endogenous glucocorticoid receptors (GR) were treated with dexamethasone (DEX) for periods of time ranging from 24 h to 2 weeks or chronically over a 2-year period. Regulation of GR protein and mRNA were examined by affinity labeling, Western blotting, and Northern blotting. Relatively short-term treatment of cells with DEX for 24 or 48 h revealed more profound down-regulation of GR protein than of GR mRNA. However, by 2 weeks of DEX treatment, the levels of both receptor protein and mRNA were both maximally down-regulated. Cells that had been chronically DEX treated (for up to 2 years) had no measurable GR protein or mRNA. The down-regulation of receptor protein and RNA that occurred after 2 weeks of DEX treatment is completely reversible upon DEX removal, whereas reversibility did not occur with cells that had been chronically treated with DEX. Furthermore, transfection of a glucocorticoid responsive reporter plasmid into these chronically DEX-treated cells demonstrated that these cells were no longer responsive to steroid treatment. However, cotransfection of a plasmid encoding the human GR into these chronically DEX-treated cells resulted in restored production of GR and responsiveness to hormone, indicating that the defect in these cells occurs only at the receptor level.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Northern
  • Blotting, Western
  • Dexamethasone / pharmacology*
  • Down-Regulation
  • HeLa Cells
  • Humans
  • Immunohistochemistry
  • RNA, Messenger / metabolism
  • Receptors, Glucocorticoid / drug effects*
  • Time Factors
  • Transfection

Substances

  • RNA, Messenger
  • Receptors, Glucocorticoid
  • Dexamethasone